芦康沙妥珠单抗二线治疗EGFR突变晚期非小细胞肺癌的成本-效用分析
潘旻, 葛坤坤, 居文祥, 朱同明, 沈爱宗
Cost-Utility Analysis of Sacituzumab Tirumotecan for the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer
PAN Min, GE Kunkun, JU Wenxiang, ZHU Tongming, SHEN Aizong
医药导报
.
2026, (8): 1439
-1446
.
DOI: 10.3870/j.issn.1004-0781.2026.08.019